CARDIOPROTECTION DURING PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH MYOCARDIAL INFARCTION

QR Code

CARDIOPROTECTION DURING PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH MYOCARDIAL INFARCTION

Currently, stent implantation is considered as the most efficient way to restore coronary blood flow upon myocardial infarction. Although counterintuitively, rapid cardiac reperfusion aggravates myocardial injury, increasing the necrosis area. A number of approaches to protect the ischemic myocardiu...

Full description

Saved in:

Bibliographic Details
Main Authors:	IVAN E. Vereschagin, VLADIMIR I. Ganyukov, IRINA N. Sizova, EVGENIY I. Vereschagin
Format:	Article
Language:	Russian
Published:	Kemerovo State Medical University 2017-12-01
Series:	Фундаментальная и клиническая медицина
Subjects:	острый инфаркт миокарда кардиопротекция реперфузионные поражения миокарда стентирование коронарной артерии myocardial infarction cardioprotection myocardial reperfusion injury coronary stenting
Online Access:	https://fcm.kemsmu.ru/jour/article/view/73
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

FOURTH UNIVERSAL DEFINITION OF MYOCARDIAL INFARCTION. FOCUS ON THE TYPE 2 MYOCARDIAL INFARCTION
by: OLGA L. Barbarash, et al.
Published: (2018-12-01)

THE PREDICTIVE VALUE OF THE RESULTS OF LABORATORY DIAGNOSTIC TOOL IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION COMPLICATED BY DIABETES
by: R. D. Kurbanov, et al.
Published: (2013-06-01)

RELEVANCE AND ROLE OF RISK FACTORS IN THE DEVELOPMENT OF MYOCARDIAL INFARCTION
by: Андрей Георгиевич Петров, et al.
Published: (2021-06-01)

The case of myocardial infarction the young woman through 6 months after childbirth
by: N. V. Porodenko, et al.
Published: (2015-12-01)

The prevalence of modifiable risk factors for atherosclerosis in patients with myocardial infarction
by: K. A. Kireev, et al.
Published: (2016-02-01)

TYPE 2 DIABETES MELLITUS AND DEPRESSION ARE PREDICTORS OF ADVERSE ANNUAL OUTCOME IN PATIENTS WITH MYOCARDIAL INFARCTION
by: Nataliay. Ardashova, et al.
Published: (2016-09-01)

GENETIC ASPECTS OF MYOCARDIAL INFARCTION: PROBLEMS AND PERSPECTIVES
by: P. A. Shesternya, et al.
Published: (2012-02-01)

Influence of blockers of the renin-angiotensin-aldosterone system on the functional state of the right ventricle myocardial infarction left ventricular anterior wall
by: G. V. Tolparov
Published: (2016-06-01)

COMPLIANCE RESEARCH CONCEPTS AS A BASIS FOR UNDERSTANDING ADHERENCE TO TREATMENT IN PATIENTS WITH MYOCARDIAL INFARCTION
by: Андрей Георгиевич Петров, et al.
Published: (2021-06-01)

CONCEPT OF MEDICAL AND PHARMACEUTICAL CARE FOR MYOCARDIAL INFARCTION AS A PROSPECTIVE FORM OF SERVICE TO THE POPULATION
by: Андрей Георгиевич Петров, et al.
Published: (2021-04-01)

Retrospective analysis of gender differences in the progression and treatment of acute myocardial infarction in the Republic of Komi
by: O. N. Kurochkina, et al.
Published: (2018-02-01)

LIMITATIONS ON PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ST-SEGMENT ELEVATION ACUTE MYOCARDIAL INFARCTION IN THE CLINICAL PRACTICE
by: V. V. Kashtalap, et al.
Published: (2016-03-01)

Current clinical and epidemiological portrait of a patient with acute myocardial infarction (by the data of the regional vascular center)
by: E. Yu. Kovalchuk, et al.
Published: (2015-06-01)

DYNAMICS OF INCIDENCE WITH MYOCARDIAL INFARCTION IN THE POPULATION OF KUZBASS AND THE RUSSIAN FEDERATION FOR THE PERIOD 2011-2019
by: Андрей Георгиевич Петров, et al.
Published: (2022-03-01)

CHRONOLOGICAL FEATURES OF ACUTE CORONARY SYNDROME / ACUTE MYOCARDIAL INFARCTION (MATERIALS TO REGISTER)
by: O. U. Urinov
Published: (2014-09-01)

COMPREHENSIVE ASSESSMENT OF THE MORTALITY OF THE POPULATION OF THE RUSSIAN FEDERATION AND KUZBASS FROM MYOCARDIAL INFARCTION FOR THE PERIOD 2012-2020
by: Андрей Георгиевич Петров, et al.
Published: (2022-03-01)

Mechanisms of the cardioprotective effect of lithium
by: A. V. Mukhomedzyanov, et al.
Published: (2025-04-01)

EFFECT OF STATINS ON SERUM CONCENTRATION OF INFLAMMATORY MARKERS AND MATRIX METALLOPROTEINASES IN PATIENTS WITH ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
by: TAMARA B. Pecherina, et al.
Published: (2019-03-01)

COMPLEX ASSESSMENT OF RISK FACTORS FOR PRECISE CHOICE OF REVASCULARIZATION STRATEGY IN ST ELEVATION MYOCARDIAL INFARCTION AND MULTIVESSEL CORONARY DISEASE
by: R. S. Tarasov, et al.
Published: (2016-02-01)

PROBLEMS OF RATIONAL CHOICE OF MEDICINAL PREPARATIONS IN PATIENTS WITH MYOCARDIAL INFARCTION
by: Николай Владимирович Абрамов, et al.
Published: (2024-02-01)

Long-term prognosis of CHD depends on fat tissue levels of lipophylic antioxidants and polyunsaturated fatty acids in patients with acute myocardial infarction
by: I. G. Shiman, et al.
Published: (2004-08-01)

RELATION OF PRO-INFLAMMATORY MARKERS IN MEN AND WOMEN WITH ONE YEAR OUTCOMES AFTER MYOCARDIAL INFARCTION
by: E. V. Tavlueva, et al.
Published: (2015-10-01)

METHODOLOGICAL APPROACH TO MONITORING PHARMACOPROPHYLACTIC MEASURES OF DEVELOPMENT OF MYOCARDIAL INFARCTION BASED ON ASSESSMENT AND PREDICTION OF PSYCHOSOCIAL RISK FACTORS
by: Андрей Георгиевич Петров, et al.
Published: (2021-09-01)

THE CASE OF Q-WAVE MYOCARDIAL INFARCTION IN A 35-YEARS-OLD FEMALE
by: A. B. Tashtanaliev, et al.
Published: (2012-04-01)

Случай стрессиндуцированной кардиомиопатии
by: V. A. Stolyarov, et al.
Published: (2012-02-01)

IMPORTANCE OF SCREENING FOR PHARMACEUTICAL AND MEDICAL PREVENTION OF CARDIOVASCULAR DISEASES
by: Андрей Георгиевич Петров, et al.
Published: (2021-04-01)

INFLUENCE OF THE FACTOR FAMILY HISTORY ON THE RISK OF CORONARY HEART DISEASE
by: J. A. Behbudova
Published: (2015-03-01)

POTENTIAL OF THE MODERN ACE INHIBITOR ZOFENOPRIL IN CLINICAL PRACTICE: CARDIOPROTECTIVE, ANTI-ISCHEMIC, AND ANTIATHEROGENIC EFFECTS
by: M. G. Bubnova
Published: (2013-02-01)

Cardioprotection Through Pharmacological Activation of Sirtuin 5 in a Murine Model of Acute Myocardial Infarction
by: Castiello C, et al.
Published: (2025-06-01)

GENDER SPECIFICS OF THE RISK FACTORS AND RELATION WITH MYOCARDIAL INFARCTION IN PATIENTS OF VARIOUS AGE GROUPS
by: I. N. Suspitsina, et al.
Published: (2016-06-01)

Regulation of angiogenesis in experimental myocardial infarction zone by application of multipotent mesenchymal stem cells
by: V. Yu. Mikhailichenko, et al.
Published: (2015-04-01)

PECULIAR FEATURES OF PTCA IN CORONARY PATIENTS WITH BIFURCATION LESIONS
by: A. O. Oleynik, et al.
Published: (2002-10-01)

Значение биохимического исследования мозгового натрийуретического пептида у больных c диффузной В-крупноклеточной лимфомой
by: М. О. Егорова, et al.
Published: (2014-04-01)

Review of patients' opinions of quality of inpatient care at the cardiac units offering different care and treatment intensity
by: N. I. Vishnyakov, et al.
Published: (2015-03-01)

MECHANISMS OF PARASYMPATHETIC INFLUENCES ON THE HEART IN THE DEVELOPMENT OF OF THE EFFECT ANTIISCHEMIC DISTANT CONDITIONING MYOCARDIUM
by: A. G. Mrochek, et al.
Published: (2014-03-01)

ПРИМЕНЕНИЕ ЛЕВОСИМЕНДАНА В ПЕРИОПЕРАЦИОННОМ ПЕРИОДЕ У БОЛЬНЫХ С ОСТРЫМ КОРОНАРНЫМ СИНДРОМОМ ПРИ АОРТОКОРОНАРНОМ ШУНТИРОВАНИИ
by: B. М. Тоdurov, et al.
Published: (2017-12-01)

Cardioprotective effect of lithium ascorbate in an <i>in vivo</i> model of myocardial infarction
by: E. V. Plotnikov, et al.
Published: (2024-10-01)

Cardioprotective Properties Of Xenon
by: A. I. Shpichko, et al.
Published: (2020-10-01)

IMPACT OF SECONDARY PREVENTION EDUCATIONAL PROGRAM ON ANXIETY, QUALITY OF LIFE, AND COMPLIANCE IN PATIENTS WITH MYOCARDIAL INFARCTION
by: DARIA YU. Sedykh, et al.
Published: (2019-03-01)

Cardioprotective Effects of Bosentan in Rats Subjected to Lung Ischemia–Reperfusion Injury
by: Şevki Mustafa Demiröz, et al.
Published: (2025-07-01)